Journal
PLOS NEGLECTED TROPICAL DISEASES
Volume 10, Issue 5, Pages -Publisher
PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pntd.0004582
Keywords
-
Categories
Funding
- Gottfried und Julia Bangerter-Rhyner-Stiftung
- Novartis Foundation for Medical Biological Research [13A13]
- Swiss National Science Foundation [320030-125316, 31003A-112196]
- Bill and Melinda Gates Foundation [OPP1032350]
- National Health and Medical Research Council (NHMRC) Senior Research Fellowship [1043345]
- UK MRC [MR/K014676/1]
- National Institutes of Health [AI063135, AI46919, TW007872]
- Australian Agency for International Development
- Victorian State Government OIS grant
- NHMRC IRIISS grant
- MRC [MR/K014676/1] Funding Source: UKRI
- Swiss National Science Foundation (SNF) [320030_125316] Funding Source: Swiss National Science Foundation (SNF)
- Medical Research Council [MR/K014676/1] Funding Source: researchfish
Ask authors/readers for more resources
Plasmodium vivax has the ability to relapse from dormant parasites in the liver weeks or months after inoculation, causing further blood-stage infection and potential onward transmission. Estimates of the force of blood-stage infections arising from primary infections and relapses are important for designing intervention strategies. However, in endemic settings their relative contributions are unclear. Infections are frequently asymptomatic, many individuals harbor multiple infections, and while high-resolution genotyping of blood samples enables individual infections to be distinguished, primary infections and relapses cannot be identified. We develop a model and fit it to longitudinal genotyping data from children in Papua New Guinea to estimate the incidence and seasonality of P vivax primary infection and relapse. The children, aged one to three years at enrolment, were followed up over 16 months with routine surveys every two months. Blood samples were taken at the routine visits and at other times if the child was ill. Samples positive by microscopy or a molecular method for species detection were genotyped using high-resolution capillary electrophoresis for P vivax MS16 and msp1F3, and P falciparum msp2. The data were summarized as longitudinal patterns of success or failure to detect a genotype at each routine time-point (eg 001000001). We assume that the seasonality of P vivax primary infection is similar to that of P falciparum since they are transmitted by the same vectors and, because P falciparum does not have the ability to relapse, the seasonality can be estimated. Relapses occurring during the study period can be a consequence of infections occurring prior to the study: we assume that the seasonal pattern of primary infections repeats over time. We incorporate information from parasitological and entomology studies to gain leverage for estimating the parameters, and take imperfect detection into account. We estimate the force of P vivax primary infections to be 11.5 (10.5, 12.3) for a three-year old child per year and the mean number of relapses per infection to be 4.3 (4.0, 4.6) over 16 months. The peak incidence of relapses occurred in the two month interval following the peak interval for primary infections: the contribution to the force of blood-stage infection from relapses is between 71% and 90% depending on the season. Our estimates contribute to knowledge of the P vivax epidemiology and have implications for the timing of intervention strategies targeting different stages of the life cycle.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available